相似文献
1
What goes around comes around: modeling malaria transmission from humans back to mosquitos.
J Clin Invest. 2018 Apr 2;128(4):1264-1266. doi: 10.1172/JCI120260. Epub 2018 Mar 12.
2
Transmission blocking malaria vaccines.
Vaccine. 2001 Mar 21;19(17-19):2309-14. doi: 10.1016/s0264-410x(00)00521-1.
3
Efficacy model for mosquito stage transmission blocking vaccines for malaria.
Parasitology. 2008 Nov;135(13):1497-506. doi: 10.1017/S0031182008000280. Epub 2008 Feb 7.
4
Mosquito stage, transmission blocking vaccines for malaria.
Curr Opin Infect Dis. 2007 Oct;20(5):476-81. doi: 10.1097/QCO.0b013e3282a95e12.
5
Uses of mosquito-stage transmission-blocking vaccines against Plasmodium falciparum.
Trends Parasitol. 2011 May;27(5):190-6. doi: 10.1016/j.pt.2010.12.011. Epub 2011 Feb 1.
6
Transmission-blocking activity induced by malaria vaccine candidates Pfs25/Pvs25 is a direct and predictable function of antibody titer.
Malar J. 2007 Aug 8;6:107. doi: 10.1186/1475-2875-6-107.
7
Antibody Therapy Goes to Insects: Monoclonal Antibodies Can Block Plasmodium Transmission to Mosquitoes.
Trends Parasitol. 2020 Nov;36(11):880-883. doi: 10.1016/j.pt.2020.08.009. Epub 2020 Oct 6.
8
Mosquito-based transmission blocking vaccines for interrupting Plasmodium development.
Microbes Infect. 2008 Jul;10(8):845-9. doi: 10.1016/j.micinf.2008.05.004. Epub 2008 May 22.
9
Strategies & recent development of transmission-blocking vaccines against .
Indian J Med Res. 2016 Jun;143(6):696-711. doi: 10.4103/0971-5916.191927.
10
Development of a transmission-blocking malaria vaccine: progress, challenges, and the path forward.
Vaccine. 2014 Sep 29;32(43):5531-9. doi: 10.1016/j.vaccine.2014.07.030. Epub 2014 Jul 29.
本文引用的文献
1
A controlled human malaria infection model enabling evaluation of transmission-blocking interventions.
J Clin Invest. 2018 Apr 2;128(4):1551-1562. doi: 10.1172/JCI98012. Epub 2018 Mar 12.
2
malERA: An updated research agenda for malaria elimination and eradication.
PLoS Med. 2017 Nov 30;14(11):e1002456. doi: 10.1371/journal.pmed.1002456. eCollection 2017 Nov.
3
malERA: An updated research agenda for diagnostics, drugs, vaccines, and vector control in malaria elimination and eradication.
PLoS Med. 2017 Nov 30;14(11):e1002455. doi: 10.1371/journal.pmed.1002455. eCollection 2017 Nov.
4
malERA: An updated research agenda for basic science and enabling technologies in malaria elimination and eradication.
PLoS Med. 2017 Nov 30;14(11):e1002451. doi: 10.1371/journal.pmed.1002451. eCollection 2017 Nov.
5
Controlled Human Malaria Infection: Applications, Advances, and Challenges.
Infect Immun. 2017 Dec 19;86(1). doi: 10.1128/IAI.00479-17. Print 2018 Jan.
6
Effect of transmission intensity on hotspots and micro-epidemiology of malaria in sub-Saharan Africa.
BMC Med. 2017 Jun 30;15(1):121. doi: 10.1186/s12916-017-0887-4.
7
Discovering New Transmission-Blocking Antimalarial Compounds: Challenges and Opportunities.
Trends Parasitol. 2016 Sep;32(9):669-681. doi: 10.1016/j.pt.2016.04.017. Epub 2016 May 18.
8
Piperaquine Monotherapy of Drug-Susceptible Plasmodium falciparum Infection Results in Rapid Clearance of Parasitemia but Is Followed by the Appearance of Gametocytemia.
J Infect Dis. 2016 Jul 1;214(1):105-13. doi: 10.1093/infdis/jiw128. Epub 2016 Apr 7.
9
Antimalarial activity of artefenomel (OZ439), a novel synthetic antimalarial endoperoxide, in patients with Plasmodium falciparum and Plasmodium vivax malaria: an open-label phase 2 trial.
Lancet Infect Dis. 2016 Jan;16(1):61-69. doi: 10.1016/S1473-3099(15)00320-5. Epub 2015 Oct 5.
10
The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015.
Nature. 2015 Oct 8;526(7572):207-211. doi: 10.1038/nature15535. Epub 2015 Sep 16.
Zotero 插件